Literature DB >> 914364

Chronic active hepatitis in patients with and without hepatitis B surface antigenemia.

A Pár, K Barna, G Bajtai, M Balázs, A Patakfalvi, A Gógl.   

Abstract

This study was designed to compare the clinical and immunological characteristics of the hepatitis B surface antigen (HBsAg)-positive and HBsAg-negative (cryptogenic) forms of chronic active hepatitis. The data of 48 patients with chronic active hepatitis, 24 with persistent HBs antigenemia and 24 without HBsAg, were analysed. HBsAg was detected by counter-immunoelectrophoresis and radioimmunoassay. The clinical features, biochemical liver function tests, immunoglobulins, complement C3, antoantibodies, and cell-mediated immunoreactivity of the two forms of the disease were compared. Cirrhosis was found to occur more frequently at the time of diagnosis in the HBsAg-negative group, and the serum alkaline phosphatase level was raised significantly compared to the HBsAg-positive form. The elevation of the IgG level was greater in the cryptogenic form, but the difference was not statistically significant compared to the HBsAg-positive patients. There was a marked difference in the frequency of the mitochondrial antibodies, but not of the antinuclear factor and other autoantibody-like serum factors. Lymphoblastic transformation revealed a similar diminution in response to phytohaemagglutinin stimulation in both groups of patients compared to the normal controls. An increase of the 3H-thymidine incorporation was seen after stimulation with human liver mitochondrial antigen, and leukocyte migration inhibition could be observed with this antigen in both forms of chronic active hepatitis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 914364     DOI: 10.1007/bf01639751

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  27 in total

1.  Trigger factors and HL-A antigens in chronic active hepatitis.

Authors:  J Lindberg; A Lindholm; P Lundin; S Iwarson
Journal:  Br Med J       Date:  1975-10-11

2.  "Auto-immune" chronic hepatitis.

Authors:  I R Mackay; S Whittingham
Journal:  Postgrad Med       Date:  1967-01       Impact factor: 3.840

3.  High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis.

Authors:  R M Galbraith; M Smith; R M Mackenzie; D E Tee; D Doniach; R Williams
Journal:  N Engl J Med       Date:  1974-01-10       Impact factor: 91.245

4.  Relation between Australia antigen and autoimmune hepatitis.

Authors:  H Popper; I R Mackay
Journal:  Lancet       Date:  1972-05-27       Impact factor: 79.321

5.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

6.  Natural history of hepatitis-associated antigen-positive chronic liver disease.

Authors:  F J Dudley; P J Scheuer; S Sherlock
Journal:  Lancet       Date:  1972-12-30       Impact factor: 79.321

Review 7.  [Significance of immunologic reactions for the diagnosis and pathogenesis of chronic hepatitis].

Authors:  K Schumacher
Journal:  Klin Wochenschr       Date:  1969-09-15

8.  Tritiated-thymidine uptake in mixed leucocyte cultures: effect of specific activity and exposure time.

Authors:  B Bain
Journal:  Clin Exp Immunol       Date:  1970-02       Impact factor: 4.330

9.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

10.  Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody.

Authors:  C M Ling; L R Overby
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.